Proporsi Hiperurisemia pada Populasi Hipertensi Essensial Suku Aceh di Kabupaten Aceh Utara

  Agamah ES, Srinivasan SR, Webber LS, Berenson GS (1991): Serum uric acid and its relations to cardiovascular disease risk factors in children and young adults from a biracial community: The Bogalusa Heart Study. J Lab

  Clin Med , 118:241-249.

  Alderman MH, Cohen H, et al (1999). Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients. Hypertension, 34:144- 150 Alderman, MH (2007). Uric Acid and Cardiovascular Disease. Circulation: 880-83.

  Aminullah A, Rukman Y, Munasir Z, Sastroasmoro S (2007). Variabel dan Hubungan antar Variabel. In: Sastroasmoro S dan Ismael S (ed). Dasar –Dasar Metodologi Penelitian Klinis Edisi Ketiga. Jakarta: Sagung Seto , 255-78.

  Bakri S, Lawrences (2008). Genetika Hipertensi, dalam Hipertensi dan Ginjal, 19-31. Becker & Meenaskshi J. Clinical gout and pathogenesis of hyperuricaemia (2005). In Arthritis and Allied Conditions. A Textbook of Rheumatology Ed- 13. Baltimore. Williams & Wilkins a Wavelry comp, 2303-2339. Beevers G,Lip GY,et al (2001). ABC of hypertension (The pathophysiology of hypertension). BMJ, 322 : 912-916. Berry CE and JM Hare (2004). Xanthine Oxidoreductase and Cardiovascular Disease: Molecular Mechanism and Pathophysiological Implications. Am J Physiol : 589-606. Blumenfeld JD and Laragh JH (2008). Hypertension and the kidney from Brenner and Rector’s. The Kidney Ed-8, 1465-1516. Bradlow A (1998). Symptomless hyperuricaemia in patients with essential hypertension and normal renal function. Journal of Human Hypertension, 12: 147-148. Bulpitt CJ (1975). Serum Uric Acidin hypertensive patients” British Heart Journal, 37: 1210-1215.

  Brown MJ, Palmer CR, Casteigne A. Morbidity and mortality in patients randomized to double blind treatment with a long acting calcium channel blocker or diuretic in the International Nifedipine GITS Study : Intervention as a Goal in Hypertension Treatment (INSIGHT) (2000). Lancet ;536: 366- 372. Campo C, Ruilope LM, Segura J (2001). Serum urate as a marker of hypertension severity. J Hypertension, in press.

  Canon PJ, Stason WB, Demartini FE, Laragh JH, Sommers SC (1966). Hyperuricemia in primary and renal hypertension. New England Journal of Medicine ; 275:457-464.

  Cohen MG, Emmerson BT (1994). Gout in Rheumatology, JH Klippel, PA Dippe (eds), Part 2. St Louis Baltimore. Mosby : 12.1-12.16. Conen D, Wietlisbach V, et al (2004). Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 4:1-9. Cooper RS, Tayo B (2008). Hypertension Primer: The Essentials of High Blood Pressure : Basic Science, Population Science, Clinical Management by Izzo JL, Sica DA, Black HR (eds) Ed-4. Lippincott Williams & Wilkins, B (74): 240-242. Culleton BF, Larson MG, Kannel WB, Levy D (2006).Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med, 131:7-13. Emmerson, BT (1983). Hyperuricaemia and Gout in Clinical Practice. ADIS Health SciencePress, Sidney. Feig DI, Kang DH, Johnson RJ (2008). Uric Acid and Cardiovascular Risk. N Eng J Med: 1811-21. Feig DI. Uric Acid and Hypertension (2011). Semin Nephrol, 31: 441-446. Fessel WJ (1979). Renal outcomes of gout and hyperuricemia. American journal of medicine, 67: 74 - 82. Ghazali MV, Sastromihardjo S, Rochani S, Soelaryo T, Pramulyo H. Studi Cross-Sectional (2007). In: Sastroasmoro S dan Ismael S (ed). Dasar –Dasar Metodologi Penelitian Klinis Edisi Ketiga. Jakarta: Sagung Seto : 112-26.

  Goldstein HS, Manowitz P (1993). Relation between serum uric acid and blood pressure in adolescents. Annals of Hum Biology, 20(5): 423- 431. Hayden MR, Tyagi SC (2004). Uric Acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutrition & Metabolism, I ;10: 1-15. Hediger MA, Johnson RJ, Miyazaki H, EndouH (2005). Molecular Physiology of Urate Transport. Am J Physiol :125-33. Heinig M and RJ Johnson (2006). Role of Uric Acid in Hypertension, Renal Disease, and Metabolic Syndrome. Cleveland Clinic Journal of Medicine :1059-64. Iseki K, Oshiro S, et al (2001). Significance of Hyperuricemia on the Early Detection of Renal Failure in a Cohort of Screened Subjects. Hypertension Res, 24:691-697. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kannelis J, Watanabe S, Tuttle KR (2003). Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension, 41:1183-1190. Johnson RJ, Segal MS,Srinivas T, et al (2005) . Essensial Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenic Link? J Am Soc Nephrol, 16:1909-1919. Kaplan NM (2002). Primary Hypertension: pathogenesis. Kaplan’s clinical hypertension. Ed-8 Philadelphia. Lippincott Williams & Willkins, 56-135. Kelly WN, Wortmann RL (1997). Crystal-associated synovitis: gout and hyperuricemia. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology. Ed-5 Philadelphia. WB Saunders, 1313-47. Kinsey D, Walther R, Wise HS, Smithwick R (1961). Incidence of hyperuricemia in 400 hypertensive patients” Circulation, 24:972. Kolbel F, Gregorova I, Souka J. Serum uric acid in hypertensives (1965). Lancet, 1; 519. Kuang-HY, Yeong-JJW (2006). Gout and Hyperuricemia : Recent Advances and a Systematic Review. J Rheumatol R.O.C, 20: 6-18.

  Kumar A, Singh YN, Malaviya AN, Chaudhary K, Tripathy S (1990). Clinical profile, therapeutic approach and outcome of gouty arthritis in northern India. Journal of Association of Physicians of India, June, 38(6): 400-402. Lawrence GS (2010). Implikasi Klinis Disfungsi Endotel dan Radikal Bebas. Makassar: FK UNHAS. Lehto S, Niskanen L, Ronnemma T, Laakso M (1998). Serum Uric Acid is A Strong Predictor of Stroke in Patients with Non-Insulin Dependent Diabetes Mellitus. Stroke : 635-39.

  Lippi G, Targher G, et al (2008). High Serum Uric Acid and a Novel Risk Factor for Type 2 Diabetes. Diabetes Care, 31(9) : e 68. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH (2007). Perkiraan Besar Sampel. In: Sastroasmoro S dan Ismael S (ed). Dasar –Dasar Metodologi Penelitian Klinis Edisi Ketiga. Jakarta: Sagung Seto, 302-30. Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, et al (2010). Uric Acid and Hypertension : Cause or Effect? Current Rheumatol, 12:108-117. Mei Z, Ying F. An Analysis on the relationship between essensial hypertension and hyperuricemia (2002). China Academic Journal Publishing House, 27 (3):223-226. Melander O (2001). Genetic Factors in Hypertension- What is known and What Does It Mean? Blood Pressure, 10 : 254-270. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG (1980). Serum Uric Acid in Essential Hypertension: an indicator of renal vascular involvement. Annals of Internal Medicine, 93:817-821 Mladinescu OF, Savoiu G, Serban C, Noveanu L, Gaita D, Muntean D (2008). The Rule of Hyperurisemia in Endothelial Dysfunction Induced by Hypertension. Romanian J. Biophys : 329-36. Nakagawa T,Kang DH (2006). Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease. Kidney International, 69: 1722-1725. Neil J. Evaluation of serum uric acid in essential hypertension (2005). Dissertation submitted to Rajiv Ghandi University of Health Science, Karnataka Bangalore.

  Niskanen L, Laaksonen DE (2006). Serum Uric Acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance, The Finnish Diabetes Prevention Study. Diabetes Care, 29: 709-711. Niskanen LK, Laaksonen DE, Nyysonen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004). Uric Acid Level as a Risk Factor for Cardiovascular and All Cause Mortality in Middle Aged Men: A Prospective Cohort Study. Arch Itern Med, :1541-46.

  Obermayr RP, Temml C, et al (2008). Elevated Uric Acid Increases the Risk for Kidney Disease. Clinical Epidemiology. J Am Soc Nephrol :1-7. Oparil S, Zaman MA, et al (2003). Pathogenesis of hypertension. Ann Intern Med, 139:761-776. Purwanto, Bambang (2009). Pathogenesis, Etiology, and Management of Hypertension and Nefrotoxic Agents. Disampaikan pada Half Day Simposium: Renal Disease Induced by Nefrotoxic Agents. Surakarta. Putra, Tjokorda Raka (2006). Hiperurisemia. In: Sudoyo dkk (ed). Buku Ajar Ilmu Peyakit Dalam Jilid II Edisi IV. Jakarta: FKUI : 1213-17. Riskerdas R (2007). Prevalensi Penyakit Kronis ( Persendian, Hipertensi, Stroke pada Penduduk) dalam 1 tahun terakhir Menurut Karakteristik Responden di NAD: 79-80. Ruilope LM and Rodicio JL (2001). The Kidney in Arterial Hypertension. Nephrol Dial Transplant, 16 (Suppl 1): 50-52. Ruilope LM, Lahera V, Rodicio JL, Romero JC (1994). Are renal hemodynamics a key factor in the development and maintanance of arterial hypertension in humans? Hypertension 1994;23:3-9. Ruilope LM (2001). Kidney function, a sensitive predictor of cardiovascular risk. Am J Hypertension, in press. Savoiu G, Serban C, et al (2008). The Role of Hyperuricemia in Endothelial Dysfunction Induced by Hypertension. Romanian J. Biophys, 18 (4): 329-336. Schumacer Jr HR. Hyperuricaemia and Gout (1992). In Rheumatology APLAR, 243-293. Sidabutar RP (1990). Hipertensi Esensial. Ilmu Penyakit Dalam jilid II, Balai Penerbit FK UI Jakarta : 205-212.

  The Seventh Report on the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2004). NIH Publication No. 04-5230, August Tykarski A. Evaluation of renal handling of uric acid in essential hypertension; hyperuricemia related to decreased urate secretion. Nephrology 1991, 59(3) : 364-368.

  Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Brunetti P (2000). Relation between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension. The PIUMA Study Hypertension : 1072-78.

  Viazzi F, Leoncini G, et al (2007). Mild Hyperuricemia and Subclinical Renal Damage in Untreated Primary Hypertension. American Journal of Hypertension, 20: 1276-1282.

  Waring WS, Esmail S (2005). How Should Serum Uric Acid Concentration be Interpreted in Patients with Hypertension. Current Hypertension Reviews : 89- 95.

  Waring WS, Webb D, Maxwell SRJ (2000). Uric acid as a risk factor for cardiovascular disease. Q J Med, 93: 707-713. Wisesa IBN, Suastika K (2009). Hubungan antara konsentrasi Asam Urat Serum dengan Resistensi Insulin Pada Penduduk Suku Bali Asli Di Dusun Tenganan Pengringsingan Karangasem. J.Peny. Dalam, vol. 10 (2) Mei : 110- 122 Yeon HK, Yeong DS, Sung PS (1986). Observation of the serum uric acid in essential hypertension. The Korean Journal of Internal Medicine, 1(1) : 14-20. Yogiantoro, Mohammad (2006). Hipertensi Esensial. In: Sudoyo dkk (ed). Buku Ajar Ilmu Peyakit Dalam Jilid I Edisi IV Jakarta FKUI : 610-14 Yongkuan W, Meijing L, Jue L (2008). Elevated serum uric acid level as predictor for cardiovascular and all cause mortality in Chinese patients with high cardiovascular risk. Journal of Geriatric Cardiology, 5:15-20. Zoccali C, Maio R 2006). Uric Acid and Endothelial Dysfunction in Essential Hypertension. J Am Soc Nephrol, 17: 1466-1471.